| Name | Title | Contact Details |
|---|---|---|
Paul Dandrow |
Executive Vice President and Chief Technology Officer | Profile |
Razvan Atanasiu |
Chief Technology Officer | Profile |
MedRep Surgical Inc is a Minnesota, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
DOCS Dermatologists of Central States is one of the largest dermatology practice groups in the United States. With over 155 providers spread across seven central states, we have been serving patients for over 40 years. Our focus is on medical, surgical...
Indiana Association for Home and Hospice Care is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pharmacy Access Solutions Inc. is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.